| __timestamp | AbbVie Inc. | PTC Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 7724000000 | 44820000 |
| Thursday, January 1, 2015 | 6387000000 | 82080000 |
| Friday, January 1, 2016 | 5855000000 | 97130000 |
| Sunday, January 1, 2017 | 6275000000 | 121271000 |
| Monday, January 1, 2018 | 7399000000 | 153548000 |
| Tuesday, January 1, 2019 | 6942000000 | 202541000 |
| Wednesday, January 1, 2020 | 11299000000 | 245164000 |
| Friday, January 1, 2021 | 12349000000 | 285773000 |
| Saturday, January 1, 2022 | 15260000000 | 325998000 |
| Sunday, January 1, 2023 | 12872000000 | 332540000 |
| Monday, January 1, 2024 | 14752000000 |
Data in motion
In the competitive landscape of the pharmaceutical industry, understanding the financial strategies of leading companies is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of AbbVie Inc. and PTC Therapeutics, Inc. from 2014 to 2023. Over this period, AbbVie Inc. consistently outpaced PTC Therapeutics, Inc. in SG&A spending, reflecting its expansive market operations. Notably, AbbVie's SG&A expenses surged by approximately 66% from 2016 to 2022, peaking in 2022. In contrast, PTC Therapeutics, Inc. exhibited a steady increase, with a notable 640% rise from 2014 to 2023. This trend underscores PTC's strategic investment in growth and market penetration. The data highlights the contrasting financial strategies of these two companies, offering insights into their operational priorities and market positioning.
Breaking Down SG&A Expenses: AbbVie Inc. vs AstraZeneca PLC
SG&A Efficiency Analysis: Comparing AbbVie Inc. and Summit Therapeutics Inc.
Who Optimizes SG&A Costs Better? AbbVie Inc. or Blueprint Medicines Corporation
AbbVie Inc. or TG Therapeutics, Inc.: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing AbbVie Inc. and Corcept Therapeutics Incorporated
Operational Costs Compared: SG&A Analysis of AbbVie Inc. and Catalyst Pharmaceuticals, Inc.
Selling, General, and Administrative Costs: AbbVie Inc. vs Veracyte, Inc.
SG&A Efficiency Analysis: Comparing Blueprint Medicines Corporation and PTC Therapeutics, Inc.
Selling, General, and Administrative Costs: Ionis Pharmaceuticals, Inc. vs PTC Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Amneal Pharmaceuticals, Inc. and PTC Therapeutics, Inc.
PTC Therapeutics, Inc. vs Merus N.V.: SG&A Expense Trends
PTC Therapeutics, Inc. or Veracyte, Inc.: Who Manages SG&A Costs Better?